Skip to main navigation Skip to search Skip to main content

Lymphoid disorders associated with HHV-8/KSHV infection: Facts and contentions

Research output: Contribution to journalArticlepeer-review

Abstract

Following the demonstration in 1994, that Kaposi's sarcoma (KS) was associated with a novel virus (KSHV or HHV-8) belonging to the lymphotropic herpes family, this virus was also found in certain lymphoid neoplasias of immunodeficient (HIV+) and immune competent hosts. The association of HHV- 8/KSHV infection is now well established with primary effusion lymphoma (PEL) or body cavity based lymphoma (BCBL) and multicentric Castleman's disease (MCD) of the plasma cell type. A possible pathogenic role of HHV-8/KSHV in other lymphoid tumours including primary central nervous system lymphoma (PCNSL) and multiple myeloma (MM) as well as some atypical lymphoproliferations and sarcoidosis has also been suggested, but this is at present a controversial matter, or not confirmed. Several HHV-8/KSHV genes, including potential oncogenes, genes homologous to various cellular genes and growth factors have been incriminated in the pathogenesis of KS and PEL/BCBL, but a common pathogenic mechanism for the clearly diverse proliferations represented by PEL, MCD and KS is at present not evident.

Original languageEnglish
Pages (from-to)8-12
Number of pages5
JournalMedical Oncology and Tumor Pharmacotherapy
Volume16
Issue number1
DOIs
Publication statusPublished - Apr 1999

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • AIDS related lymphoma
  • Angio-follicular lymphoid hyperplasia/multicentric Castleman's disease
  • Human herpes virus-8/Kaposi's sarcoma herpes virus
  • Multiple myeloma
  • Primary effusion lymphoma/body cavity based lymphoma

Fingerprint

Dive into the research topics of 'Lymphoid disorders associated with HHV-8/KSHV infection: Facts and contentions'. Together they form a unique fingerprint.

Cite this